These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9037454)

  • 1. Drug research--a change of paradigms.
    Müllner S
    Arzneimittelforschung; 1997 Jan; 47(1):105. PubMed ID: 9037454
    [No Abstract]   [Full Text] [Related]  

  • 2. Pedro Cuatrecasas.
    Cuatrecasas P
    Nat Rev Drug Discov; 2009 Jun; 8(6):446. PubMed ID: 19483706
    [No Abstract]   [Full Text] [Related]  

  • 3. Avoiding premature licensing.
    Kessel M; Hall S
    Nat Rev Drug Discov; 2006 Dec; 5(12):985-6. PubMed ID: 17201025
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical research: outlook from industry.
    Echols R
    Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug life-cycle technologies.
    Fleming E; Ma P
    Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech R&D still reeling.
    Lawrence S
    Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed scores for European research.
    Chipman A
    Nature; 2007 Nov; 450(7166):16-7. PubMed ID: 17972849
    [No Abstract]   [Full Text] [Related]  

  • 8. A changing drug supply.
    Nature; 2007 Feb; 445(7127):460. PubMed ID: 17268432
    [No Abstract]   [Full Text] [Related]  

  • 9. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D; Tear S
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract]   [Full Text] [Related]  

  • 10. Open innovation: share or die..
    Talaga P
    Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629
    [No Abstract]   [Full Text] [Related]  

  • 11. Industrial R&D paradigm shift to vaccines.
    Maggon K
    Biotechnol J; 2009 Apr; 4(4):458-61. PubMed ID: 19370719
    [No Abstract]   [Full Text] [Related]  

  • 12. A return to the fundamentals of drug discovery?
    Williams M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970
    [No Abstract]   [Full Text] [Related]  

  • 13. Employment and employability for pharmacology graduates.
    Hughes I
    Nat Rev Drug Discov; 2002 Oct; 1(10):833. PubMed ID: 12360262
    [No Abstract]   [Full Text] [Related]  

  • 14. Fresh horizons South Korea.
    Cyranoski D
    Nature; 2002 Dec; 420(6916):4-5. PubMed ID: 12478244
    [No Abstract]   [Full Text] [Related]  

  • 15. San Diego.
    Howard K
    Nature; 2003 Dec; 426(6967):689. PubMed ID: 14668871
    [No Abstract]   [Full Text] [Related]  

  • 16. Innovative drug R&D in China.
    Qi J; Wang Q; Yu Z; Chen X; Wang F
    Nat Rev Drug Discov; 2011 May; 10(5):333-4. PubMed ID: 21532556
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical R&D: the road to positive returns.
    David E; Tramontin T; Zemmel R
    Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
    [No Abstract]   [Full Text] [Related]  

  • 18. Daniel Vasella.
    Hughes B
    Nat Rev Drug Discov; 2010 Feb; 9(2):98. PubMed ID: 20118958
    [No Abstract]   [Full Text] [Related]  

  • 19. The 802 million dollars fallacy.
    Hodgson J
    Nat Biotechnol; 2004 Sep; 22(9):1076. PubMed ID: 15340464
    [No Abstract]   [Full Text] [Related]  

  • 20. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G
    Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.